medigraphic.com
ISSN 0326-3428 (Print)
Órgano de difusión científica de la Asociación Nefrológica de Buenos Aires

2021, Number 3

<< Back Next >>

Rev Nefrol Dial Traspl 2021; 41 (3)

Tuberculosis presenting as proliferative glomerulonephritis with monoclonal immunoglobulin deposits

Helvaci O, Erten Y, ISık GI, Ozet A, Hazneda R

Language: English
References: 15
Page: 202-206
PDF size: 133.88 Kb.


ABSTRACT

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits is defined as membranoproliferative glomerulonephritis like injury with monotypic Ig deposits restricted to a single light chain isotype.
Here we present a patient who presented with hypocomplementemia and nephrotic syndrome, who was initially diagnosed with proliferative glomerulonephritis with monoclonal immunoglobulin deposits. He developed disseminated tuberculosis after a brief course of immunosuppression. Successful treatment of tuberculosis resulted in the complete remission of glomerular disease and the disappearance of monoclonal protein. Hence, we believe he had Tuberculosis-related proliferative glomerulonephritis with monoclonal immunoglobulin deposits.
Treatment strategies have not been structured due to the rarity of the condition and lack of randomized trials. However, expert opinion suggests clone-based therapy. proliferative glomerulonephritis with monoclonal immunoglobulin deposits with a benign course without clone-based therapy has been reported. Patients seldom respond to classic immunosuppressants. Even some cases experience slowly progressive disease under angiotensin converting enzyme inhibition alone. There are also cases secondary to viral infections.
Our case and the particular “benign” cases lead us to an intriguing proposition that proliferative glomerulonephritis with monoclonal immunoglobulin deposits might not be a single disease. A subset of patients may be experiencing infection-related or post-infectious glomerulonephritis presenting as proliferative glomerulonephritis with monoclonal immunoglobulin deposits.


REFERENCES

  1. Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKDAtlas of Renal Pathology: MembranoproliferativeGlomerulonephritis. Am J Kidney Dis. 2015;66(3):e19- 20. doi: 10.1053/j.ajkd.2015.07.007.

  2. Hogan JJ, Alexander MP, Leung N. Dysproteinemia andthe Kidney: Core Curriculum 2019. Am J Kidney Dis.2019;74(6):822-36. doi: 10.1053/j.ajkd.2019.04.029.

  3. Leung N, Bridoux F, Hutchison CA, Nasr SH,Cockwell P, Fermand JP, et al.; International Kidneyand Monoclonal Gammopathy Research Group.Monoclonal gammopathy of renal significance: whenMGUS is no longer undetermined or insignificant.Blood. 2012;120(22):4292-5. doi: 10.1182/blood-2012-07-445304.

  4. Sethi S, Fervenza FC, Rajkumar SV. Spectrumof manifestations of monoclonal gammopathyassociatedrenal lesions. Curr Opin NephrolHypertens. 2016;25(2):127-37. doi: 10.1097/MNH.0000000000000201.

  5. Solak Y, Gaipov A, Anil M, Atalay H, Ozbek O, TurkmenK, et al. Glomerulonephritis associated with tuberculosis:a case report and literature review. Kaohsiung J Med Sci.2013;29(6):337-42. doi: 10.1016/j.kjms.2012.10.008.

  6. Bida JP, Kyle RA, Therneau TM, Melton LJ 3rd,Plevak MF, Larson DR, et al. Disease associations withmonoclonal gammopathy of undetermined significance:a population-based study of 17,398 patients. MayoClin Proc. 2009;84(8):685-93. doi: 10.1016/S0025-6196(11)60518-1.

  7. Nasr SH, Markowitz GS, Stokes MB, SeshanSV, Valderrama E, Appel GB, et al. Proliferativeglomerulonephritis with monoclonal IgG deposits:a distinct entity mimicking immune-complexglomerulonephritis. Kidney Int. 2004;65(1):85-96. doi:10.1111/j.1523-1755.2004.00365.x.

  8. Nasr SH, Satoskar A, Markowitz GS, Valeri AM, AppelGB, Stokes MB, et al. Proliferative glomerulonephritiswith monoclonal IgG deposits. J Am Soc Nephrol.2009;20(9):2055-64. doi: 10.1681/ASN.2009010110.

  9. Bhutani G, Nasr SH, Said SM, Sethi S, Fervenza FC,Morice WG, et al. Hematologic characteristics ofproliferative glomerulonephritides with nonorganizedmonoclonal immunoglobulin deposits. MayoClin Proc. 2015;90(5):587-96. doi: 10.1016/j.mayocp.2015.01.024.

  10. Gumber R, Cohen JB, Palmer MB, Kobrin SM, VoglDT, Wasserstein AG, et al. A clone-directed approachmay improve diagnosis and treatment of proliferativeglomerulonephritis with monoclonal immunoglobulindeposits. Kidney Int. 2018;94(1):199-205. doi:10.1016/j.kint.2018.02.020.

  11. Sethi S, Rajkumar SV. Monoclonal gammopathyassociatedproliferative glomerulonephritis. MayoClin Proc. 2013;88(11):1284-93. doi: 10.1016/j.mayocp.2013.08.002.

  12. Xing G, Gillespie R, Bedri B, Quan A, Zhang P, ZhouXJ. Proliferative glomerulonephritis with monoclonalIgG deposits in children and young adults. PediatrNephrol. 2018;33(9):1531-8. doi: 10.1007/s00467-018-3949-8.

  13. Bridoux F, Javaugue V, Nasr SH, Leung N.Proliferative glomerulonephritis with monoclonalimmunoglobulin deposits: a nephrologist perspective.Nephrol Dial Transplant. 2021;36(2):208-15. doi:10.1093/ndt/gfz176.

  14. van Kruijsdijk RCM, Abrahams AC, Nguyen TQ,Minnema MC, Jacobs JFM, Limper M. Clone-directedtherapy for proliferative glomerulonephritis withmonoclonal immunoglobulin depositions: is it alwaysnecessary? Two case reports and literature review. JNephrol. 2020;33(3):611-7. doi: 10.1007/s40620-020-00723-2.

  15. Fujita E, Shimizu A, Kaneko T, Masuda Y, IshiharaC, Mii A, et al. Proliferative glomerulonephritiswith monoclonal immunoglobulin G3κ depositsin association with parvovirus B19 infection. HumPathol. 2012;43(12):2326-33. doi: 10.1016/j.humpath.2012.04.004.




2020     |     www.medigraphic.com